Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway-Reference-Cited by-同舟云学术

Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway

Published:2015-04 Issue:4 Volume:67 Page:312-321
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Wu Xiafei¹,Zhang Feng¹²³,Xiong Xin¹,Lu Chunfeng¹,Lian Naqi¹,Lu Yin¹²³,Zheng Shizhong¹²³

Affiliation:

1. Department of Pharmacology, College of Pharmacy; Nanjing University of Chinese Medicine; Nanjing China

2. National First-Class Key Discipline for Traditional Chinese Medicine of Nanjing University of Chinese Medicine; Nanjing China

3. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Material Medical; Nanjing University of Chinese Medicine; Nanjing China

Funder

National Natural Science Foundation of China

Doctoral Discipline Foundation of Ministry of Education of China

National Science and Technology Supporting Program

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/iub.1348/fullpdf

Reference28 articles.

1. Liver fibrosis - from bench to bedside;Friedman;J. Hepatol. 38(Suppl,2003

2. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis;Czaja;Hepatology,2004

3. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity;Henao-Mejia;Nature,2012

4. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver;Ganz;World J. Gastroenterol,2011

5. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome;Imaeda;J. Clin. Invest.,2009

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRP3 inflammasome activation contributes to the development of the pro-fibrotic phenotype of lung fibroblasts;Biochemical Pharmacology;2024-11

2. Transcriptomic analysis reveals pharmacological mechanisms mediating efficacy of Yangyinghuoxue Decoction in CCl4-induced hepatic fibrosis in rats;Frontiers in Pharmacology;2024-05-15

3. Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

4. Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis;Journal of Nanobiotechnology;2024-01-03

5. Sesamol as a potential candidate for the treatment of hepatic fibrosis, based on its regulation of FXR/LXR axis-mediated inhibition of autophagy through crosstalk between hepatic cells and macrophage;Phytomedicine;2024-01